Duvoux C, Roudot-Thoraval F, Traissac L, Vanlemmens C, Conti F, Pageaux G, et al. Survival benefit associated with liver transplantation (LT) in patients transplanted for hepatocellular carcinoma (HCC) (abstract). J Hepatol 2001;34 (suppl. 1):48.
Survival Outcomes in Hepatocellular Carcinoma Patients Show Improvement Over Time Bladder Cancer e-Tumor Boards: Case 8: Localized Muscle Invasive Bladder Cancer Screening and Management of Metabolic Dysfunction–Associated Fatty Liver Disease in Endocrine Practice Patient Communication Strategies in Hepatoc...
HCC exhibits increased antioxidative response and survival rates in response to oxygen stress through phosphoryla- tion of KHK-A-mediated p62's aggregation51. Accumula- tion of phosphorylated p62 prevents Nrf2 degradation and results in its nuclear accumulation, which contributed to the growth of HCC...
"I am honored to have spearheaded the LEGACY trial in which we found that patients with early and advanced HCC exhibited very high response rates as well as clinically meaningful durations of response and survival, establishing TheraSphere as a standard treatment for this patient population," said ...
Conference|International Liver Cancer Association Annual Conference Although regorafenib is not currently approved, Morris Sherman, MD, PhD, already views the agent as the standard second-line therapy, with hopes for moving the agent into the frontline setting....
Hepatocellular carcinoma (HCC) is one of the most prevalent malignant tumors worldwide and represents the predominant form of liver cancer [1, 2]. This type of cancer is primarily linked to chronic infections of hepatitis B and C viruses, alcoholic liver disease, and non-alcoholic fatty liver ...
(vegetarian/vegan) have been found to be inversely associated with obesity, mixed dyslipidaemia, IR and, possibly, liver cancer [84]. However, the mechanisms behind these effects are not fully understood and require further molecular investigations. The current evidence suggests that there is not a...
Optimal liver allocation for hepatocellular carcinoma: Hurry up and Wait, but Which One When? Where else in the world of cancer but in liver transplantation for HCC is early (T1) cancer left to progress untreated, and definitive treatment ... M Schwartz,S Florman - 《American Journal of Tra...
And if we try to put 1 plus 1, this turns out to be 26 months of survival while the patient was still on the trial, and this was the cut point. Suddenly, from a few months of survival back in the 1970s for these patients, now we are discussing almost 2 years....
and gastric carcinoma6. AFP is reactivated in more than 70% of HCC patients, and serum AFP has been considered the ‘gold-standard’ biomarker for clinical liver cancer diagnosis for the past several decades5. AFP is associated with fetal defects and malformations, and abnormal levels of AFP ...